Gonzalez Xavier Viñals, Mora Francisca, Arshad Falak, Zhang Yiping, Babariya Dhruti, Wells Dagan, Tozer Amanda
Embryology Department, Aria Fertility, London, UK.
Reproductive Genetics Department, Juno Genetics, Oxford, UK.
J Reprod Infertil. 2024 Jan-Mar;25(1):66-71. doi: 10.18502/jri.v25i1.15202.
Chromosomal structural rearrangements can lead to fertility problems and recurrent miscarriages. The intricate interplay of genetics during human development can lead to subtle anomalies that may affect reproduction.
A 33-year-old woman sought fertility treatment after experiencing six miscarriages. Products of conception from the final pregnancy loss had been karyotyped, revealing a Robertsonian translocation (RT), involving chromosome 14. Fertility investigations showed low anti-Mullerian hormone (AMH) levels but otherwise normal female characteristics with normal sperm parameters of her husband were observed and both partners having a normal karyotype. Two embryos were transferred in an IVF cycle but neither resulted in a successful pregnancy. Subsequently, preimplantation genetic testing for aneuploidy (PGT-A) was applied to trophectoderm biopsy specimens from 4 embryos, which revealed abnormalities involving chromosome 14. Sperm aneuploidy testing failed to detect any increase in the incidence of aneuploidy affecting chromosome 14. Further embryos genetic testing indicated that all identified chromosome 14 abnormalities in the embryos had a maternal (oocyte) origin.
This case underscores challenges in diagnosing and managing germline mosaicism in fertility. A maternal 14;14 Robertsonian translocation, undetected in the patient's blood but impacting oocytes, likely explains recurrent miscarriage and observed embryo aneuploidies. Genetic mosaicism in reproductive medicine highlights the necessity for advanced testing and personalized treatments. Data integration from various genetic analyses could enhance managing treatment expectations and improving fertility experiences.
染色体结构重排可导致生育问题和反复流产。人类发育过程中基因的复杂相互作用可导致可能影响生殖的细微异常。
一名33岁女性在经历6次流产后寻求生育治疗。对最后一次流产的妊娠产物进行了核型分析,发现了涉及14号染色体的罗伯逊易位(RT)。生育力检查显示抗苗勒管激素(AMH)水平较低,但女性特征正常,其丈夫的精子参数正常,且双方核型均正常。在一个体外受精周期中移植了两个胚胎,但均未成功妊娠。随后,对4个胚胎的滋养外胚层活检标本进行了非整倍体植入前基因检测(PGT-A),结果显示存在涉及14号染色体的异常。精子非整倍体检测未发现影响14号染色体的非整倍体发生率有任何增加。进一步的胚胎基因检测表明,胚胎中所有已识别的14号染色体异常均起源于母体(卵母细胞)。
本病例强调了生育中诊断和管理生殖系嵌合体的挑战。患者血液中未检测到但影响卵母细胞的母体14;14罗伯逊易位,可能解释了反复流产和观察到的胚胎非整倍体现象。生殖医学中的基因嵌合体突出了先进检测和个性化治疗的必要性。整合来自各种基因分析的数据可以提高对治疗预期的管理并改善生育体验。